Posted on 08/31/2022 12:16:06 PM PDT by Twotone
The US government expects its supply of COVID-19 vaccines and antiviral treatments to run out over the next year and is preparing for them to be sold via the commercial market, the Department of Health and Human Services said on Tuesday.
President Joe Biden's administration expects to run out of federal funding for buying and distributing COVID-19 vaccines by January, although it has already bought over 170 million doses for a booster campaign later this year, according to a blog post written by Assistant Secretary for Preparedness and Response Dawn O'Connell.
The administration has procured enough of Pfizer's antiviral treatment Paxlovid to supply the pills until mid-2023, O'Connell said, but other therapeutics made by Merck & Co and AstraZeneca are likely to be sold on the commercial market sooner.
"Our goal is to transition procurement and distribution of COVID-19 vaccines and therapeutics from a federally managed system to the commercial marketplace in a thoughtful, well-coordinated manner that leaves no one behind," she wrote following a meeting with private sector representatives.
(Excerpt) Read more at jpost.com ...
IOW, the Midterm Variant will have served its purpose and they don’t want to keep fearmongering for another two years.
Pls joey take several more boosters-just to be sure.
Take fauci with you for the boosters.
Not sure the fall “campaign” for which FedGov is gearing up with respect to the revamped vexxine 2.0 is going to be met with the kind of enthusiasm among We the People that our supposed betters are planning for/hoping for.
Think about it. Most Americans state that they do not trust the government. Ten minutes later they stand in line for a government sanctioned, unproven, untested shot.
Unfortunately, some had no choice for career reasons.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.